Revolutions Medical Corporation (OTCBB: RMCP)

Revolutions Medical Corporation operates in the safety-engineered medical devices (SEMDs) arena. Its products include the Rev Vac Safety Syringe, safety blood-drawing device and the Rev Vac Safety IV Catheter. The world market for SEMDs was projected to exceed $1.6 billion last year and is forecasted to maintain a 20% annual growth rate in the near term. The Theta Report estimated the number of needles and syringes sold in the U.S. and International market combined should exceed 20 billion units in 2007. Revolutions Medical Corporation also provides software solutions and tools that are compatible with standard MRI and standard PACS. Their technology includes sorting of images; grayscale and color, 3D rendering, and automatic segmentation of images. These tools will enhance the physician's diagnostic confidence in an industry that is growing at 10% - 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion. The company is continually looking for new and improved technology through internal product development and acquisition.

Become a fan of RevMed and keep up on the latest Company developments at www.facebook.com/RevMed.

Quick Links

CEO Interview

Share Statistics

Important Company Highlights

Investment Highlights

• 3 recurring revenue business lines with blended gross margins projected to exceed 50%
• Anticipated profitability in first full year of operations, and 320% CAGR through 2014E
• 2 closest public comps have market caps of $50 MM - $100 MM , with syringe products inferior to Rev Vac

Market Opportunity

• 1 MM+ U.S. health care workers stuck with hypodermic needles annually; in some countries 90% of injections are unsafe; SEMDs now a $3 B industry, but existing syringes are sub-optimal
• Global MRI market is $1.8 B, and exploding as the Baby Boomers age; dangerous information overload as radiologist numbers stay static; new tools are required to more efficiently/effectively interpret data
• 300K annual breast cancer diagnoses in the U.S.; screening industry now a $9.5 B market; existing non- and minimally-invasive diagnostic solutions leave much to chance; a more precise tool is critically needed

Stock Information

Symbol: OTCBB: RMCP
Issue Type: Common Stock
Sector: Healthcare
Industry: Health Services

Investor Relations

Scott Key
843-518-0437
Skey@revolutionsmedical.com

Transfer Agent

American Stock Transfer & Trust Company, LLC
59 Maiden Lane
Plaza Level
New York, NY 10038
www.amstock.com

Auditors

Sutton Robinson Freeman & Co., P.C.
2727 East 21st Street, #600
Tulsa, OK 74114-3537
www.telcpa.com

Accountant

Burt P. Hodges
Accel Tax and Business Services, LLC
Accel Financial Advisors, LLC
501 Belle Hall Pkwy, Suite 102
Mount Pleasant, SC 29464
Office: 843-972-0536
Fax: 843-972-0539
www.acceltaxandbusiness.com